Among 67 patients with hematologic malignancies, or cancers that affect the blood, bone marrow or lymph nodes, 46 percent did not produce antibodies a few weeks after receiving their second dose of COVID-19 vaccine, according to an analysis led by ...
from Google Alert - health https://ift.tt/328F1BB
via IFTTT
0 comments:
Post a Comment